Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Editorial

Farm-grown superbugs: While the world acts, Canada dawdles

Barbara Sibbald
CMAJ October 02, 2012 184 (14) 1553; DOI: https://doi.org/10.1503/cmaj.120561
Barbara Sibbald
Barbara Sibbald is Deputy Editor, Analysis and Humanities, CMAJ.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

Factory farms, where thousands of animals are crammed together, are driving the growth of antibiotic-resistant organisms that cause human diseases. Poultry, swine and cattle receive low doses of antibiotics to reduce infection and enhance growth. This off-label use helps bolster the bottom line, but in the process, bacteria are developing antimicrobial resistance, which affects human health. A March 2012 World Health Organization (WHO) report states that “urgent action is needed” to limit antibiotic use in agriculture.1 It wants antibiotics to be prescribed to farm animals, instead of being routinely added to their feed. Many nations, including the United States, are taking action, but in Canada, only Quebec has passed regulations.

Agriculture plays a major role in promoting antibiotic resistance,1,2 even after accounting for other factors such as overprescribing of antibiotics by physicians and suboptimal adherence by patients. Best available evidence according to WHO indicates that use in animals accounts for well over half of all antibiotic use.1 In Canada, about 88% of the total volume (by weight of active ingredient) of antimicrobials distributed for sale are for use in animals.3

The more antibiotics are used — and, more importantly, misused — the more they selectively encourage the emergence of organisms resistant to them. Of greatest concern is the promotion of resistance to antibiotics that may currently represent the last resort for treating some highly resistant infections in humans. Use in farm animals of these antibiotics that are essential for use in humans, or of related drugs in the same class, such as avoparcin (a glycopeptide antibiotic similar to vancomycin) or virginiamycin (a streptogramin antibiotic similar to quinupristin–dalfopristin, which is our last line of defence if Staphylococcus aureus or Enterococcus infections develop resistance to vancomycin), is thus particularly alarming. The World Health Organization states that “the importance of food animals as reservoirs of resistant human pathogens is well documented.”1

In 1986, Sweden banned prophylactic use of antimicrobials in farm animals.2 Denmark banned this use of avoparcin in 1995 and virginiamycin in 1998. In 1997, the European Union (EU) banned the use of avoparcin as a growth promoter; two years later the EU recommended phasing out as soon as possible antibiotics used for growth promotion or from classes used in humans.4 This was achieved by 2005.5

Most recently, in January 2012, the US Food and Drug Administration (FDA) tried to prohibit the off-label use of cephalosporin drugs in most food-producing animals because of the threat of antibiotic resistance to human health, as cephalosporins are first-line antibiotics for empiric treatment of a broad variety of infections in humans.6 In March, a New York judge ruled that the FDA must restart a process begun 35 years ago to ban use of penicillin and tetracycline in animals for growth promotion.7 The FDA has since asked food producers to voluntarily stop using antibiotics in livestock for non-medical uses.8

In Canada, off-label drug use and prescribing is a practice of veterinary medicine; thus, it is regulated by the provinces. So far, only Quebec requires prescriptions for all antimicrobials for animals. Meanwhile, Health Canada, through its Veterinary Drugs Directorate, does not recommend off-label use for antimicrobials that are “of very high importance” to human health, including cephalosporins and fluoroquinolones, and is discussing the issue with the provinces.9

Canada should join its international counterparts and move toward banning off-label antimicrobial use in agriculture. Meanwhile, we should close loopholes in drug importation, mandate measurement and reporting of use, and scrutinize the contribution of veterinary prescriptions to appropriateness of antibiotic use. We should also support those food producers who are making efforts to increase standards of animal welfare and hygiene so as to reduce the perceived need for antimicrobials in the first place.

With stricter regulations, consumers of meat will have to pay more, but perhaps not as much as one might think. In Sweden, the resulting cost to consumers for retail meat has increased by only a few cents per kilogram.10 It’s a small price to pay in the ongoing struggle against antimicrobial resistance.

Footnotes

  • For references, see Appendix 1, available at www.cmaj.ca/lookup/suppl/doi:10.1503/cmaj.120561/-/DC1.

  • Competing interests: None declared.

PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 184 (14)
CMAJ
Vol. 184, Issue 14
2 Oct 2012
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Farm-grown superbugs: While the world acts, Canada dawdles
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Farm-grown superbugs: While the world acts, Canada dawdles
Barbara Sibbald
CMAJ Oct 2012, 184 (14) 1553; DOI: 10.1503/cmaj.120561

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Farm-grown superbugs: While the world acts, Canada dawdles
Barbara Sibbald
CMAJ Oct 2012, 184 (14) 1553; DOI: 10.1503/cmaj.120561
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Footnotes
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Antibiotic stewardship and pharmas social conscience
  • Antimicrobials in farming
  • Antimicrobials in farming
  • Farm-grown superbugs?
  • Google Scholar

More in this TOC Section

  • Regard sur la santé des personnes noires et le racisme anti-Noirs dans les systèmes de santé au Canada
  • A focus on access to health care in Canada
  • L’avenir de la médecine est ici et vous en êtes la trame narrative
Show more Editorial

Similar Articles

Collections

  • Topics
    • Canadian government
    • Global health
    • Public health

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire